Difference between revisions of "John Sleeth"
Line 21: | Line 21: | ||
Due to a major scandal in [[3023]], when a batch of synthetic molecular antibodies produced by Baker Pharmaceuticals become toxic and killed over a hundred [[Lyran Commonwealth Armed Forces]] soliders, Sleeth's company faced serious financial difficulties arising from the subsequent lawsuit and large damages payout. | Due to a major scandal in [[3023]], when a batch of synthetic molecular antibodies produced by Baker Pharmaceuticals become toxic and killed over a hundred [[Lyran Commonwealth Armed Forces]] soliders, Sleeth's company faced serious financial difficulties arising from the subsequent lawsuit and large damages payout. | ||
− | Baker's distressed state caused [[Nashan Diversified]] to attempt a takeover of the company, which Sleeth tried to | + | Baker's distressed state caused [[Nashan Diversified]] to attempt a takeover of the company, which Sleeth tried to resist, by seeking to personally acquire all Baker's publicly owned stock at a higher price than was being offered by Nashan.<ref name=HSLC></ref> Nashan was however eventually able to overcome Sleeth's effort, and acquire Baker for itself.<ref name=HHS>''Handbook: House Steiner'', Page 134</ref> |
==References== | ==References== |
Latest revision as of 20:13, 25 November 2023
John Sleeth | |
---|---|
Personal | |
Affiliation | Lyran Commonwealth |
Career | |
Profession | Corporate executive |
John Sleeth was the head of Baker Pharmaceuticals, a pharmaceutical company in the Lyran Commonwealth, as of 3024.[1]
History[edit]
Due to a major scandal in 3023, when a batch of synthetic molecular antibodies produced by Baker Pharmaceuticals become toxic and killed over a hundred Lyran Commonwealth Armed Forces soliders, Sleeth's company faced serious financial difficulties arising from the subsequent lawsuit and large damages payout.
Baker's distressed state caused Nashan Diversified to attempt a takeover of the company, which Sleeth tried to resist, by seeking to personally acquire all Baker's publicly owned stock at a higher price than was being offered by Nashan.[1] Nashan was however eventually able to overcome Sleeth's effort, and acquire Baker for itself.[2]